probenecid has been researched along with Dermatitis Herpetiformis in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Dermatitis Herpetiformis: Rare, chronic, papulo-vesicular disease characterized by an intensely pruritic eruption consisting of various combinations of symmetrical, erythematous, papular, vesicular, or bullous lesions. The disease is strongly associated with the presence of HLA-B8 and HLA-DR3 antigens. A variety of different autoantibodies has been detected in small numbers in patients with dermatitis herpetiformis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mirzoev, IuA | 1 |
| Grebeniuk, VN | 1 |
| Lashmanova, AP | 1 |
| Polianskaia, NP | 1 |
1 other study available for probenecid and Dermatitis Herpetiformis
| Article | Year |
|---|---|
[Complex treatment of patients with Duhring's dermatitis herpetiformis using drugs with antioxidant effects].
Topics: Adult; Antioxidants; Child; Dapsone; Dermatitis Herpetiformis; Drug Therapy, Combination; Female; Hu | 1988 |